28.7% revenue growth masks margin miss vs. FY27 guide

Revenue ₹3,335.2 Cr, 28.7% YoY growth, 10% QoQ

ISCS 21.9% YoY, GFS 50.6% YoY — both confirmed

232.2 Cr EBITDA ÷ 3,335.2 Cr revenue = 6.96% ≈ 7%, vs 6.7% prior

Q1 ISCS margin 8.1%; management cited implementation costs + Q4 price corrections. Unverified for Q2.

Strong revenue growth (28.7% YoY), but NPM collapsed to 0.7% from 2.7% YoY (reported PAT -68.4%). Below FY27 EBITDA margin guide (7.0% vs 7.3–7.4%).

Q1 delivered 7.0% vs. FY27 guide of 7.3–7.4% (−30 to −40 bps). Management attributes to ISCS implementation costs and GFS pricing headwinds; reaffirmed trajectory but without raising Q1 number.

Prior call claimed 9.5–10%; Q1 delivered 8.1%. Management now says recovery in Q2 (to 9%), not held at prior level. QoQ: 9.3% (Q4) → 8.1% (Q1) = 120 bps sequential dip.

Q1 new wins ₹543 Cr (21% of Q1 FY26 revenue, all-time high); prior Q4 was ₹524 Cr. Pipeline rose from ~₹6,100 Cr to ₹7,500 Cr. Conversion rate 20–25% historically.

Reported PAT −68.4% YoY due to InvIT gain non-recurrence; adjusted operational PAT +156% YoY. Management highlighted leverage and trajectory improvement, but headline weakness is stark.

Q4 had price-correction benefit from customers (typical year-end); Q1 does not. Plus new contract ramp-up. Will recover to 9% in Q2.

Volumes and cost optimizations are real; incremental business is sustainable. Growth may slow but margins will hold around this level.

Biggest risk is recession; we mitigate via customer visibility. We are early to know and can cost-optimize proactively. No red flags today.

Confident of 9% in Q2. Plan to take to 9.5–10% by Q4.

We firmly believe in profitable growth. All projects we win are accretive to existing margins. Profit growth will have bigger multiple than revenue growth.

Target ₹2,000 Cr by year 5. H2 FY27 will see initial revenue. Highly regulated market; margin accretive (high single digits like ALA itself).

Historical track record 20–25%; expect similar in 12–15 months.

Utilization ~85%, room to improve. New projects are customer-backed, so capex is tied to contracts. Depreciation as % of revenue will decline.

Q1 delivered 28.7% YoY. With ₹7,500 Cr pipeline and 20–25% conversion, trajectory is strong.

Q1 8.1% vs. prior 9.5–10% guide. Implementation costs cited; unproven recovery timeline.

Q1 delivered 7.0% (−30 to −40 bps miss). Management reaffirmed trajectory but explained as timing, not strategy shift.

Q1 delivered 4.1%. Management cautious on further uplift; freight rates and cost optimizations may not be fully repeatable.

ISCS EBITDA margin fell to 8.1% from 8.3% YoY despite 22% revenue growth. Management blames temporary implementation costs, but sequential drop from Q4 9.3% is steep. If recovery to 9% fails, FY27 EBITDA guide (7.3–7.4%) will be missed by 100+ bps.

Reported PAT ₹22.5 Cr down 68.4% YoY. While non-operating (InvIT gain), headline PAT weakness signals operational leverage is not yet flowing to bottom line. NPM 0.7% is critically weak despite revenue growth and EBITDA margin expansion.

MD explicitly cited recession as the biggest risk. War-related freight rate volatility, container availability squeeze, and potential manufacturing slowdown could compress customer volumes and pricing power.

GFS EBITDA margin jumped to 4.1% from 2.1% YoY. Uplift driven by volume growth, cost takeouts, and favorable freight rates. If war-related rate spikes reverse or cost savings are one-time, margin could slide back below 3%.

ALA JV targets ₹2,000 Cr by year 5 and H2 FY27 revenue start. Aerospace/defence is highly regulated; certification must be achieved before commercial operations. Delays are possible.